W D Kobasa

745 total citations
22 papers, 585 citations indexed

About

W D Kobasa is a scholar working on Pharmacology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, W D Kobasa has authored 22 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 11 papers in Infectious Diseases and 10 papers in Clinical Biochemistry. Recurrent topics in W D Kobasa's work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Bacterial Identification and Susceptibility Testing (10 papers). W D Kobasa is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (13 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Bacterial Identification and Susceptibility Testing (10 papers). W D Kobasa collaborates with scholars based in United States and Brazil. W D Kobasa's co-authors include Donald Kaye, Jerome A. Boscia, Matthew E. Levison, Elías Abrutyn, Jaime Carrizosa, Deborah R. Kaye, Keith S. Kaye, Oksana M. Korzeniowski, David M. Kaye and Kenneth M. Kaye and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and The Journal of Infectious Diseases.

In The Last Decade

W D Kobasa

22 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W D Kobasa United States 12 350 144 132 129 116 22 585
Jerome A. Boscia United States 17 649 1.9× 169 1.2× 291 2.2× 122 0.9× 282 2.4× 28 900
Rolf Lundholm Sweden 8 323 0.9× 110 0.8× 121 0.9× 41 0.3× 153 1.3× 10 633
W N M Hustinx Netherlands 10 471 1.3× 51 0.4× 41 0.3× 85 0.7× 50 0.4× 16 813
A. Voss Spain 9 339 1.0× 132 0.9× 43 0.3× 69 0.5× 54 0.5× 12 644
Raymond C. Bartlett United States 17 297 0.8× 321 2.2× 61 0.5× 104 0.8× 23 0.2× 57 942
Frédérique Bouchand France 15 214 0.6× 211 1.5× 56 0.4× 63 0.5× 65 0.6× 52 603
G. K. Daikos Greece 16 209 0.6× 140 1.0× 19 0.1× 252 2.0× 24 0.2× 63 648
Jin Seo Lee South Korea 15 307 0.9× 152 1.1× 32 0.2× 62 0.5× 35 0.3× 47 661
Udo B. Hoyme Germany 13 387 1.1× 24 0.2× 87 0.7× 60 0.5× 98 0.8× 59 622
R.A. Simpson United Kingdom 14 127 0.4× 109 0.8× 29 0.2× 23 0.2× 47 0.4× 20 567

Countries citing papers authored by W D Kobasa

Since Specialization
Citations

This map shows the geographic impact of W D Kobasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W D Kobasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W D Kobasa more than expected).

Fields of papers citing papers by W D Kobasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W D Kobasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W D Kobasa. The network helps show where W D Kobasa may publish in the future.

Co-authorship network of co-authors of W D Kobasa

This figure shows the co-authorship network connecting the top 25 collaborators of W D Kobasa. A scholar is included among the top collaborators of W D Kobasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W D Kobasa. W D Kobasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boscia, Jerome A., W D Kobasa, & Donald Kaye. (1988). Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy. 32(2). 262–264. 7 indexed citations
2.
Boscia, Jerome A., et al.. (1987). Lack of Association Between Bacteriuria and Symptoms in the Elderly. The Journal of Urology. 138(3). 681–681. 1 indexed citations
3.
Boscia, Jerome A., W D Kobasa, & Donald Kaye. (1987). Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis. Antimicrobial Agents and Chemotherapy. 31(3). 458–460. 3 indexed citations
4.
Boscia, Jerome A., et al.. (1986). Epidemiology of bacteriuria in an elderly ambulatory population. The American Journal of Medicine. 80(2). 208–214. 153 indexed citations
5.
Boscia, Jerome A., et al.. (1986). Teicoplanin Compared with Vancomycin for Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus epidermidis. The Journal of Infectious Diseases. 154(1). 69–75. 25 indexed citations
6.
Boscia, Jerome A., et al.. (1986). A lack of association between bacteriuria and symptoms in the elderly. The American Journal of Medicine. 81(6). 979–982. 131 indexed citations
7.
Boscia, Jerome A., et al.. (1986). Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy. 29(3). 461–463. 24 indexed citations
8.
Boscia, Jerome A., W D Kobasa, & Donald Kaye. (1985). Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis. Antimicrobial Agents and Chemotherapy. 27(5). 708–711. 9 indexed citations
9.
Kobasa, W D & Donald Kaye. (1983). Aztreonam, cefoperazone, and gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis in rabbits. Antimicrobial Agents and Chemotherapy. 24(3). 321–324. 13 indexed citations
10.
Kobasa, W D, et al.. (1983). Therapy for Experimental Endocarditis Due to Staphylococcus epidermidis. Clinical Infectious Diseases. 5(Supplement_3). S533–S537. 43 indexed citations
11.
Boscia, Jerome A., Oksana M. Korzeniowski, W D Kobasa, et al.. (1983). Pharmacokinetics of cefoperazone in normal subjects and patients with hepatosplenic schistosomiasis. Journal of Antimicrobial Chemotherapy. 12(4). 407–410. 5 indexed citations
12.
Boscia, Jerome A., et al.. (1983). Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis. Antimicrobial Agents and Chemotherapy. 23(3). 385–389. 17 indexed citations
13.
Kobasa, W D, et al.. (1982). Effect of cimetidine and antacid on gastric microbial flora. Infection and Immunity. 36(2). 518–524. 50 indexed citations
14.
Carrizosa, Jaime, et al.. (1982). Cefazolin versus cephalothin in β-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental model. Journal of Antimicrobial Chemotherapy. 9(5). 387–393. 11 indexed citations
15.
Carrizosa, Jaime, et al.. (1981). Cefoperazone treatment of experimental endocarditis. Antimicrobial Agents and Chemotherapy. 19(5). 773–776. 7 indexed citations
16.
Kaye, Donald, W D Kobasa, & Keith S. Kaye. (1980). Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics. Antimicrobial Agents and Chemotherapy. 17(6). 957–960. 28 indexed citations
17.
Carrizosa, Jaime, W D Kobasa, & Donald Kaye. (1979). Effectiveness of Nafcillin, Methicillin, and Cephalothin in Experimental Staphylococcus aureus Endocarditis. Antimicrobial Agents and Chemotherapy. 15(5). 735–737. 17 indexed citations
18.
Kaye, Donald, et al.. (1979). Treatment of Experimental Staphylococcus aureus Abscesses: Comparison of Cefazolin, Cephalothin, Cefoxitin, and Cefamandole. Antimicrobial Agents and Chemotherapy. 15(2). 200–203. 11 indexed citations
19.
Carrizosa, Jaime, et al.. (1978). Experimental streptococcal endocarditis. The early vegetation.. PubMed. 102(10). 518–21. 5 indexed citations
20.
Carrizosa, Jaime, W D Kobasa, & Donald Kaye. (1975). Antagonism between chloramphenicol and penicillin in streptococcal endocarditis in rabbits.. PubMed. 85(2). 307–11. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerome A. Boscia Breakdown of academic impact, for papers by Rolf Lundholm Breakdown of academic impact, for papers by W N M Hustinx Breakdown of academic impact, for papers by A. Voss Breakdown of academic impact, for papers by Raymond C. Bartlett Breakdown of academic impact, for papers by Frédérique Bouchand Breakdown of academic impact, for papers by G. K. Daikos Breakdown of academic impact, for papers by Jin Seo Lee Breakdown of academic impact, for papers by Udo B. Hoyme Breakdown of academic impact, for papers by R.A. Simpson
Rankless by CCL
2026